News | March 15, 2023

Bio-Rad Launches PTC Tempo 96 And PTC Tempo Deepwell Thermal Cyclers

Enhanced usability to support PCR applications in basic and translational research, process development, and quality control

Bio-Rad Laboratories, Inc., a global leader in life science research and clinical diagnostic products, today announced the launch of its PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers, designed to optimize PCR applications such as sequencing, cloning, and genotyping.

The PTC Tempo 96 and PTC Tempo Deepwell Thermal Cyclers are a new generation of conventional PCR thermal cyclers from Bio-Rad. The latest design is built with a refreshed, intuitive user interface and flexible connectivity features for streamlining protocol management. A motorized lid allows for automation compatibility and modern instrument control for workflows. The PTC Tempo Thermal Cycler is engineered to maintain superior thermal performance, delivering accurate results alongside the flexibility to expand and grow within the laboratory.

“The new line of PTC Tempo Thermal Cyclers delivers the same reliability and high-quality performance that Bio-Rad has been providing to customers for over 30 years,” said Steven Blakely, Senior Director, Gene Expression, Bio-Rad. “With this engineering expertise, we have developed and manufactured robust and efficient thermal cyclers that scientists need and want.”

These PCR instruments offer enhanced usability with features designed to support academic, commercial, and biopharma labs in conducting basic and translational research, process development, and quality control.

For more information, visit about the PTC Tempo Thermal Cycler

About Bio-Rad
Bio-Rad Laboratories, Inc. is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With 70 years of focus on quality and customer service, our products advance the scientific discovery process and improve healthcare. Our customers are universities, research institutions, hospitals, biotechnology and pharmaceutical companies, as well as public health and commercial laboratories including food safety and environmental quality testing facilities. Based in Hercules, California, Bio-Rad has a global network of operations with approximately 8,300 employees worldwide and $2.8B in revenues in 2022. For more information,  visit

Source: Bio-Rad Laboratories, Inc.